Given the increasing number of cases of liver cancer, nonalcoholic steatohepatitis, and non-alcoholic fatty liver disease worldwide, investigations on the role of Cav1 in liver diseases are warranted. This evidence concerns the gene CAV1 and metabolic dysfunction-associated steatotic liver disease.